Cardiovascular Toxicity Incidence, Pathogenesis and Treatment Strategies /
The cardiovascular system is vital for human well-being, playing key roles in thermoregulation, nutrient transport, fluid balance, and protection from infection. Cardiovascular diseases are leading causes of morbidity and mortality. Pharmaceuticals, illicit drugs, toxins, and environmental factors c...
Bewaard in:
| Coauteur: | |
|---|---|
| Andere auteurs: | , , , |
| Formaat: | Elektronisch E-boek |
| Taal: | Engels |
| Gepubliceerd in: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| Editie: | 1st ed. 2025. |
| Reeks: | Advances in Biochemistry in Health and Disease,
33 |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1007/978-3-031-90598-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Inhoudsopgave:
- 1
- Introduction
- 2
- Definition, incidence and types of cardiac toxicology
- 3
- Diagnosis, methods, and biomarkers in the detection of cardiovascular toxicity
- 4
- Overview of the features and molecular mechanisms of drug-induced cardiotoxicity
- 5
- Anti-cancer treatment and cardiovascular toxicity
- 6
- Overview on the effect of conventional chemotherapeutics in cardiovascular toxicity
- 7
- Effect of immune check point inhibitors-associated myocarditis and underlying mechanisms
- 8.-Androgen deprivation therapy and cardiovascular toxicity
- 9
- Mechanisms of Ponatinob-induced Cardiotoxicity
- 10
- Effect of proteosome inhibitors and underlying mechanisms in cardiovascular toxicity
- 11
- Effect of anti-inflammatory agents and mechanisms in cardiovascular toxicity
- 12
- Cardiotoxic effects of catecholamines
- 13
- Effect of agents used in CNS diseases in cardiovascular toxicity
- 14
- Effect of anti-allergic drugs in cardiovascular toxicity
- 15
- Cancer therapy-related pulmonary hypertension
- 16
- Diabetic foot ulcer and cardiac autonomic neuropathy
- 17
- Cardiovascular toxicity of metallopharmaceutics - clinical and experimental insights
- 18
- Interaction between genetic and epigenetic factors in the pathogenesis of cardiovascular toxicity
- 19
- Nutrition, gut microbiota, and the pathogenesis of cardiovascular toxicity
- 20
- Pharmacogenomics in the prediction of cardiovascular toxicity
- 21
- Use of human stem cells in the prediction of cardiovascular toxicity
- 22
- Potential role of nutraceuticals in the prevention of cardiovascular toxicity
- 23
- Potential new drug targets modulating the drug induced oxidative stress in the cardiovascular toxicity
- 24
- Effect of exercise on cardiovascular toxicity
- 25
- Physical Medicine and Rehabilitation Strategies in Cardiotoxicity.